Press release from Companies: Clean interim safety review of RhoVac’s clinical phase IIb study in prostate cancer

Press release from Companies: RhoVac receives approval to initiate a long-term follow-up of clinical phase I/II patients

Press release from Companies: RhoVac får godkännande för att initiera långtidsuppföljning av patienterna som deltog i kliniska fas I/II-studien

Press release from Companies: RhoVac Confirms Forecast – BRaVac Phase IIb study recruitment to close in Quarter 3 2021

Press release from Companies: RhoVac bekräftar tidigare prognos-rekrytering till fas IIb studien BRaVac beräknas avslutas i kvartal 3 2021

Press release from Companies: Kommuniké från årsstämma i RhoVac AB (publ)

More from the company: RhoVac's events during May - August

More from the company: RhoVac’s evenemang under maj - augusti

Reports: RhoVac AB presenterar delårsrapport Q1 2021

More from the company: RhoVac brought to the attention of the European Innovation Council during World Immunization Week

More from the company: RhoVac uppmärksammat av Europeiska Innovationsrådet under World Immunisation Week

Press release from Companies: RhoVac AB offentliggör årsredovisning och koncernredovisning för 2020